Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease

被引:392
作者
Dominguez-Villar, Margarita [1 ,2 ,3 ]
Baecher-Allan, Clare M. [3 ]
Hafler, David A. [1 ,2 ,3 ]
机构
[1] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
基金
美国国家卫生研究院;
关键词
MULTIPLE-SCLEROSIS; INTERLEUKIN-12; LYMPHOCYTES; VIVO;
D O I
10.1038/nm.2389
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD4(+) CD25(high)CD127(low)/-forkhead box p3 (Foxp3)(+) regulatory T cells (T-reg cells) possess functional plasticity. Here we describe a higher frequency of T helper type 1 (T(H)1)-like, interferon-gamma (IFN-gamma)-secreting Foxp3(+) T cells in untreated subjects with relapsing remitting multiple sclerosis (RRMS) as compared to healthy control individuals. In subjects treated with IFN-beta, the frequency of IFN-gamma(+) Foxp3(+) T cells is similar to that in healthy control subjects. In vitro, human T-reg cells from healthy subjects acquire a T(H)1-like phenotype when cultured in the presence of interleukin-12 (IL-12). T(H)1-like T-reg cells show reduced suppressive activity in vitro, which can partially be reversed by IFN-gamma-specific antibodies or by removal of IL-12.
引用
收藏
页码:673 / 675
页数:3
相关论文
共 15 条
[1]   Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis [J].
Astier, Anne L. ;
Meiffren, Gregory ;
Freeman, Samuel ;
Hafler, David A. .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (12) :3252-3257
[2]   Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4(+) T cells via CD40 ligand [J].
Balashov, KE ;
Smith, DR ;
Khoury, SJ ;
Hafler, DA ;
Weiner, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (02) :599-603
[3]   T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects [J].
Beima, KM ;
Miazgowicz, MM ;
Lewis, MD ;
Yan, PS ;
Huang, THM ;
Weinmann, AS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (17) :11992-12000
[4]   IL-17-producing human peripheral regulatory T cells retain suppressive function [J].
Beriou, Gaelle ;
Costantino, Cristina M. ;
Ashley, Charles W. ;
Yang, Li ;
Kuchroo, Vijay K. ;
Baecher-Allan, Clare ;
Hafler, David A. .
BLOOD, 2009, 113 (18) :4240-4249
[5]   Interferon-β therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production [J].
Byrnes, AA ;
McArthur, JC ;
Karp, CL .
ANNALS OF NEUROLOGY, 2002, 51 (02) :165-174
[6]   INVIVO ACTIVATED LYMPHOCYTES-T IN THE PERIPHERAL-BLOOD AND CEREBROSPINAL-FLUID OF PATIENTS WITH MULTIPLE-SCLEROSIS [J].
HAFLER, DA ;
FOX, DA ;
MANNING, ME ;
SCHLOSSMAN, SF ;
REINHERZ, EL ;
WEINER, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (22) :1405-1411
[7]   The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation [J].
Koch, Meghan A. ;
Tucker-Heard, Glady's ;
Perdue, Nikole R. ;
Killebrew, Justin R. ;
Urdahl, Kevin B. ;
Campbell, Daniel J. .
NATURE IMMUNOLOGY, 2009, 10 (06) :595-U57
[8]   CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis [J].
Kumar, Manoj ;
Putzki, Norman ;
Limmroth, Volker ;
Remus, Ralph ;
Lindemann, Monika ;
Knop, Dietmar ;
Mueller, Norbert ;
Hardt, Cornelia ;
Kreuzfelder, Ernst ;
Grosse-Wilde, Hans .
JOURNAL OF NEUROIMMUNOLOGY, 2006, 180 (1-2) :178-184
[9]   CCR5 is characteristic of Th1 lymphocytes [J].
Loetscher, P ;
Uguccioni, M ;
Bordoli, L ;
Baggiolini, M ;
Moser, B .
NATURE, 1998, 391 (6665) :344-345
[10]   IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis [J].
Martinez-Forero, Ivan ;
Garcia-Munoz, Ricardo ;
Martinez-Pasamar, Sara ;
Inoges, Susana ;
de Cerio, Ascension Lopez-Diaz ;
Palacios, Ricardo ;
Sepulcre, Jorge ;
Moreno, Beatriz ;
Gonzalez, Zaira ;
Fernandez-Diez, Begona ;
Melero, Ignacio ;
Bendandi, Maurizio ;
Villoslada, Pablo .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (02) :576-586